| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0007 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.25 | 0.0009 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.23 | 0.001 |